Identifying adeno‐associated virus ( AAV ) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses
FEBS Open Bio · 2024
DOI: 10.1002/2211-5463.13894 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2024. Verfasst von Farhana A Sarker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Clinical School, Faculty of Medicine and Health, University of Sydney, Australia. Hauptthemen laut MEDLINE: Dependovirus, Glioma, Genetic Vectors, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine and Health, University of Sydney.
Abstract (Originalsprache)
To improve the translation of preclinical cancer research data to successful clinical effect, there is an increasing focus on the use of primary patient‐derived cancer cells with limited growth in culture to reduce genetic and phenotype drift. However, these primary lines are less amenable to standardly used methods of exogenous DNA introduction. Adeno‐associated viral (AAV) vectors display tropism for a wide range of human tissues, avidly infect primary cells and have a good safety profile. In the present study, we therefore used a next‐generation sequencing (NGS) barcoded AAV screening method to assess transduction capability of a panel of 36 AAVs in primary cell lines representing high‐grade glioma (HGG) brain tumours including glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG). As proof of principle, we created a reporter construct to analyse activity of the transcriptional co‐activators yes‐associated protein (YAP) and transcriptional co‐activator with PDZ‐binding motif (TAZ). Transcriptional activation was monitored by promoter‐driven expression of the Timer fluorescent tag, a protein that fluoresces green immediately after transcription and transitions to red fluorescence over time. As expected, attempts to express the reporter in primary HGG cells from plasmid expression vectors were unsuccessful. Using the top candidate from the AAV screen, we demonstrate successful AAV‐mediated transduction of HGG cells with the YAP/TAZ dynamic activity reporter. In summary, the NGS‐screening approach facilitated screening of many potential AAVs, identifying vectors that can be used to study the biology of primary HGG cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Hospital Clinical School, Faculty of Medicine and Health, University of Sydney, Australia.
- Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia.
- Translational Vectorology Research Unit, Faculty of Medicine and Health, Children's Medical Research Institute, The University of Sydney, Westmead, Australia.
- Australian Genome Therapeutics Centre, Children's Medical Research Institute and Sydney Children's Hospitals Network, Westmead, Australia.
- Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Warsaw, Poland.
ORCID-Profile: Geraldine M O'Neill
Förderung
- Faculty of Medicine and Health, University of Sydney
Zitieren
APA
Sarker, F. A., Chen, Y., Westhaus, A., Lisowski, L., & O'Neill, G. M. (2024). Identifying adeno‐associated virus ( AAV ) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13894
Vancouver
Sarker FA, Chen Y, Westhaus A, Lisowski L, O'Neill GM. Identifying adeno‐associated virus ( AAV ) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses. FEBS Open Bio. 2024. doi:10.1002/2211-5463.13894
BibTeX
@article{Sarker2024,
author = {Sarker, Farhana A and Chen, Yuyan and Westhaus, Adrian and Lisowski, Leszek and O'Neill, Geraldine M},
title = {Identifying adeno‐associated virus ( AAV ) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses},
journal = {FEBS Open Bio},
year = {2024},
doi = {10.1002/2211-5463.13894}
}
EUVIMED